VANCOUVER, British Columbia--(BUSINESS WIRE)--Oct. 27, 2005--Inflazyme Pharmaceuticals Ltd. (TSX:IZP) today announced the completion of the reorganization announced on September 20, 2005. In September, we raised an initial $3.4 million by restructuring one of our wholly-owned subsidiaries. Today, we completed the reorganization by selling all of the Company’s holdings in this subsidiary for an additional $3.6 million. Total net proceeds from the reorganization are approximately $7 million.
